Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

A big opportunity and executing well

Findi
3:27pm
January 31, 2025
Findi (FND) is an ASX-listed fintech that operates in India’s large and fast-growing market. It has ~215k ATM/payment locations and processes >1 billion transactions per year. FND operates two key businesses: 1) an ATM solutions business, which deploys and manages ATMs through both Brown Label (BLA) and White Label ATM (WLA) agreements; and 2) a ‘Digital’ payments business (Findipay + BankIT), focused on dynamic payments and digital banking. The attraction of the FND story, in our view, is its established BLA operations, which give it a solid foothold in the sizeable Indian ATM/payments market. Furthermore, the areas management is targeting for future expansion (WLA and Digital) are far less capital intensive than FND’s traditional BLA operations, which should facilitate increasing returns and cashflow. We initiate coverage on FND with an ADD rating, with the stock trading at a ~40% discount to our A$7.17 blended valuation.

FY25’s 15% PBT growth guidance is looking tougher

Judo Capital Holdings
3:27pm
January 31, 2025
Monthly data that APRA releases on the domestic assets and liabilities of authorised deposit-taking institutions indicates JDO’s loan and deposit growth in 1H25 was slower than what we had expected for JDO to achieve its 15% PBT growth guidance for FY25. We’ve adjusted our forecasts downwards which had a valuation impact, but our 12 month target price has lifted upwards as we move closer in time to the strong growth in earnings that JDO is expected to generate. HOLD, $1.96 target price.

Steady progress although US growth still lumpy

ImpediMed
3:27pm
January 31, 2025
IPD posted its 2Q25 cash flow report which demonstrated solid sales growth and showed the cost base is under control. The US installed base growth was disappointingly below our forecast, although the pipeline of opportunities suggest subsequent quarters should see a meaningful step up in sales. Reimbursement coverage has increased to 75% of the US population which we think will move to over 90% in the next few quarters. We have revised our forecasts down to reflect the lower unit growth and as a result our valuation has reduced to A$0.17 (was A$0.19). Speculative Buy recommendation has been maintained.

Buying windows opening up

Sandfire Resources
3:27pm
January 31, 2025
2Q25 production and earnings were slightly below market expectations. SFR’s steady net debt reduction toward net cash during FY26 (our forecast) is pleasing, with consistent mine production at higher rates also a highlight. We like SFR’s methodical approach in unlocking incremental equity value, primarily via mine-plan optimisation and life extension. We now apply a small premium when deriving our upgraded target of $10.55ps. SFR remains a Hold, but better value buying windows are emerging on volatility.

A good house in a good neighbourhood

Digico Infrastructure REIT
3:27pm
January 30, 2025
DigiCo Infrastructure REIT (DGT) is a diversified owner, operator and developer of data centres, with a portfolio of 13 assets across Australia and North America. The stabilised leased assets (North America) underpin income, while the marquee value-add asset (SYD1) is a high-quality property with significant expansion potential. We see the existing portfolio underpinning the current share price, with the expansion / development potential the key source of future outperformance. The business has a slew of potential catalysts, centred on index inclusion (Mar-25) and the potential lease up of expansion space across the existing portfolio. We initiate coverage with an ADD recommendation and $5.60/share target price.

2Q25: From 6-7’s to 11’s

BETR Entertainment
3:27pm
January 30, 2025
BlueBet Holdings (BBT) posted another strong quarterly result today, coming in slightly ahead of our estimates. The company achieved an EBITDA positive half earlier than expected, driven by accelerated synergy gains and solid trading performance. Since the merger, betr margins have risen from 6-7% (before) to 11%, highlighting the success of the merger and the strength of its operating platform and promotional engine in reactivating dormant accounts. Our 12-month price target increases to $0.43 (previously $0.36). In 2Q25, BBT's cash active clients grew 20% sequentially, exceeding our expectations and reaching 144,697 by the end of the period (MorgansF: 12.5% growth). Turnover hit $357m, 2% above our estimates, while gross win reached $52.2m at a 14.6% margin (MorgansF: $50m). This translated to a strong net win margin of 11% (MorgansF: 10.2%). Encouragingly, BBT reports that 2Q25 trading momentum has carried into 3Q25. We expect a statutory benefit in 1H25 following the US exit, though some costs from the wind-down will offset this. The company reaffirmed its confidence in achieving over 10% market share through both organic and inorganic growth. BBT will release its interim result on 27 February 2025. We have taken our forecast FY25 EBITDA up from $4.2m to $4.9m.

Pivotal period for the USA

Credit Corp
3:27pm
January 30, 2025
CCP’s 1H25 NPAT of A$44.1m, +32% on pcp, was inline. Guidance was reaffirmed. Divisional composition was largely in-line, with the USA slightly below expectations (offset by Lending slightly ahead). USA was +16% on pcp, however -15% HOH. USA execution is pivotal in FY25 to prove up the ability of the division to deliver sustainable growth for CCP. Management’s commentary on operational performance was incrementally positive and purchasing guidance is sound; however a flow through to earnings from 2H25 is required for market confidence. Backing management’s execution in delivering on USA divisional growth expectations over FY25/26 is needed. We think the valuation point (~11.5x FY25PE) provides enough upside and risk/reward to do so. Add maintained.

Success at Onslow is key

Mineral Resources
3:27pm
January 30, 2025
2Q’FY25 production across MIN’s operations was slightly weak against consensus expectations and MorgansF. 1H’FY25 capital expenditure of A$1.4bn is well above consensus expectations and MorgansF, and operating costs across MIN’s lithium mines remained elevated over the quarter. Net debt now sits at ~A$5.1bn which is a +15% increase from the end of FY24. We maintain our HOLD rating with an updated target price of A$35ps (previously A$39ps).

Early positive signs that brand spend is working

Airtasker
3:27pm
January 29, 2025
Airtasker’s (ART) 2Q25 trading update highlighted a marketplace that is beginning to build positive momentum, in our view, particularly given the offshore growth rates reported in the period. Group revenue increased ~11% on the pcp to A$13.6m (20.8% monetisation rate). Key takeaways in the update were: 1) the strong pcp revenue growth rate in the UK of ~95%, highlighting positive early results of the marketing campaigns; and 2) the top of funnel health in the ART marketplaces (booked tasks up ~11% on pcp). We make upward revisions to our FY25F-FY27F revenue estimates factoring in the current update as well as the uptick in expected revenue from the significantly increased marketing spend over the coming periods. Our DCF/Multiples derived price target increases to A$0.56 (from A$0.52). Add maintained.

Promotions keep kicking

Accent Group
3:27pm
January 29, 2025
AX1 provided a trading update for 1H25 performance which was broadly in line with consensus expectations with EBIT of ~$80m. Sales and margins were affected by a heavily promotional environment, particularly in the last six weeks. Whilst gross margins were negatively impacted by promotional activity, and down 100bps year-on-year, the cost of doing business (CODB) appears to have been managed better than expected. We have made minor downward revisions to our forecasts for FY25/26. Our valuation is $2.40 and we retain our ADD recommendation.

News & Insights

Michael Knox, Chief Economist, reveals how the OECD and RBA’s outdated assumptions about global trade fail to account for China’s Marxist-Leninist economic strategies.

This morning, I was asked to discuss Sarah Hunter’s presentation from yesterday. Sarah, the Assistant Governor and Chief Economist at the Reserve Bank of Australia (RBA), delivered a detailed and competent discussion on the conventional view of tariffs’ impact on the international economy. She highlighted that tariffs typically increase inflation and reduce economic output, a perspective echoed by the OECD in a similar presentation overnight. Sarah’s analysis focused on the potential shocks tariffs could cause, particularly their effects on GDP and inflation.

Drawing on my experience as an Australian trade commissioner and my work in Australian embassies, I found her presentation particularly interesting. My background allowed me to bring specialist knowledge to the conversation, which I believe gave me an edge. Notably, I observed that the RBA seems to lack analysts closely tracking individual policymakers in the Trump administration, such as Scott Bessent, whose views on tariffs and competition differ from the general assumptions. The conventional view assumes a world of perfectly competitive countries adhering to international trade rules and unlikely to engage in conflict—a scenario that doesn’t align with the current global trade environment, especially between China and the United States.

China, operating as a Marxist-Leninist economy, aims to dominate global markets by building monopolies in areas like rare earths, nickel, copper, and other base metals. It maintains a managed exchange rate, despite promises to the International Monetary Fund for a freely floating currency. If China allowed its currency, the RMB, to float, it would likely appreciate significantly, increasing imports and reducing its trade surplus. This would create a more balanced international trade environment, potentially reducing the need for other countries to impose tariffs. However, major institutions like the OECD and RBA seem to misjudge the nature of this trade shock, relying on outdated assumptions about global trade dynamics.

The international community also appears to overlook specific U.S. policy intentions, such as those articulated by figures like Peter Navarro and Scott Bessent. The U.S. aims to use tariffs selectively to bolster industries like pharmaceuticals, precision manufacturing, and motor vehicles. This misunderstanding leads public institutions to perceive unspecified risks, as reflected in Sarah’s otherwise able presentation. Because the RBA and similar institutions view the world as fraught with undefined risks, they are inclined to keep interest rates low, responding to perceived threats rather than an equilibrium model.

Interestingly, data from the U.S. economy contradicts the expected negative impacts of tariffs. The Chicago Fed National Activity Indicator, a reliable gauge of economic growth since the 2008 financial crisis, shows U.S. growth above the long-term trend for the first four months of this year. This suggests resilience despite tariff-related shocks. Ideally, growth will slow later this year, prompting the Federal Reserve to cut rates, facilitating a soft landing and a decline in the U.S. dollar to boost global commodity prices. However, this nuanced outlook wasn’t evident in yesterday’s presentation.

Moreover, the anticipated rise in U.S. inflation due to tariffs isn’t materialising. Scott Bessent recently noted that U.S. CPI inflation is lower than expected, with core inflation shown as the (16% trimmed mean) at 3% for the past two months . Core inflation  excluding  food and energy CPI  is only at 2.8%. This suggests that Chinese suppliers are absorbing tariff costs to maintain market share, rather than passing them on as higher prices. Recent Chinese data supports this, showing a slight decline in manufacturing confidence and coal consumption, indicating reduced factory output and electricity use. This points to a modest slowdown in China’s economy. So far the expected negative effects on U.S. prices and output are not occurring.

In summary, the fears expressed by institutions like the RBA and OECD about the Trump administration’s trade policies appear overstated. The U.S. economy is not experiencing the predicted declines in output or increases in inflation. While these effects may emerge later, the current data suggests that the risks are not as severe as anticipated, highlighting a disconnect between theoretical models and real-world outcomes.

Read more
Michael Knox outlines the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and his own analysis for Australia.

Today, I’m presenting the first page of my updated presentation, which focuses on GDP growth and inflation expectations for major economies. Before diving into that, I want to clarify a point about U.S. trade negotiations that has confused some media outlets.

In the previous Trump Administration ,there was single trade negotiator, Robert Lighthizer, held a cabinet position with the rank of Ambassador. This time, to expedite negotiations and give them more weight, Trump has appointed two additional cabinet-level officials to handle trade talks with different regions. For Asian economies, Scott Bessent and Ambassador Jamison Greer, who succeeded Lighthizer and previously served on the White House staff, are managing negotiations, including those with China. For Europe, Howard Lutnick, the Commerce Secretary, and Ambassador Greer are negotiating with the European Trade Representative. When the EU representative visits Washington, D.C., they meet with Lutnick and Greer, while Chinese or Japanese representatives engage with Bessent and Greer.

In my presentation today, I’m outlining the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and my own analysis for Australia.

For the U.S., the best-case scenario is a soft landing, with growth slowing but remaining positive at 1.3% this year and rising to 1.7% next year. This slowdown allows the Federal Reserve to continue cutting interest rates, leading to a decline in the U.S. dollar. This in turn ,triggers a recovery in commodity prices. These prices have stabilized and are now trending upward, with an expected acceleration as the dollar weakens.

U.S. headline inflation is projected to be just below 3% next year, with higher figures this year driven by tariff effects.



Global Economic Perspective

In the Euro area, growth is accelerating slightly, from just under 1% this year to 1.2% next year, with inflation expected to hit the 2% target this year and dip to 1.9% next year.

China’s GDP growth is forecast  at 4% for both this year and next, a step down from previous 5% rates, reflecting a significant slump in domestic demand and very low inflation  Chinese Inflation is only  :   0.2% last year, 0.4% this year, and 0.9% next year.  Despite a massive fiscal push, with a budget deficit around 8% of GDP, China’s debt-to-GDP ratio is rising faster than the U.S.. Yet this is  yielding more modest  domestic growth.

India, on the other hand, continues to outperform, with 6.5% GDP growth last year, 6.2% this year, and  6.3%  next year, surpassing earlier projections.

Read more
In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia.

Positive earnings surprise

In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia. For all the volatility in markets caused by US trade policy, the results were positive. For all the 187 high profile and blue-chip companies in our International Watchlist, the median EPS beat vs consensus was 3.2%, nearly twice that recorded in the December quarter (1.8%). 37% of companies exceeded consensus EPS expectations by more than 5% and only 9% missed by more than 5%. Communication Services was the most positive sector, led by Magnificent 7 companies Alphabet and Meta Platforms. The median EPS beat in that sector was 13%. Consumer Discretionary was the biggest disappointment (though only a mild one) with EPS falling 0.6% short of analyst estimates on a median basis.

Alphabet and Meta among the best performers

Across our Watchlist, some of the best performing stocks in terms of EPS beats were Alphabet, Boeing, Uniqlo-owner Fast Retailing, Meta Platforms, Newmont and The Walt Disney Company. Notable misses came from insurance broker Aon, BP, PepsiCo, Starbucks, Tesla and UnitedHealth. The latter saw by far the worst share price performance over reporting season, its earnings weakness compounded by the resignation of its CEO and the launch of a fraud investigation by the Department of Justice. British luxury fashion label Burberry had the best performing share price as it gains traction in its turnaround plan.

Tariffs were the main talking point (of course)

The timing of President Trump’s ‘Liberation Day’ on 2 April, just before the March quarter results started rolling in, guaranteed that US tariffs would be the main talking point throughout reporting season. Most companies took the line that higher tariffs presented a material risk to global growth and inflation. The rapidly shifting sands of US trade policy mean the impact of tariffs is highly uncertain. This didn’t stop many companies from trying to estimate the impact on their profits. This ranged from the very precise ($850m said RTX) to the extremely vague (‘a few hundred million dollars’ hazarded Abbott Laboratories). The rehabilitation of AI as a systemic driver of long-term value was a key theme of reporting season, with many companies reporting what Palantir Technologies described as an ‘unstoppable whirlwind of demand’ and others indicating an increase in planned AI investment. The deterioration in consumer confidence was another key talking point, though most companies could only express concern about a possible future softening in demand rather than any actual evidence of a hit to sales.

Our International Focus List continues to outperform

In this report, we also report on the performance of the Morgans International Focus List, which is now up 25.3% since inception last year, outperforming the benchmark S&P 500 by 20.4%.


Morgans clients receive exclusive insights such as access to our latest International Reporting Season article.

Contact us today to begin your journey with Morgans.

      
Contact us
      
      
Find an adviser
      
Read more